Nord/LB Reiterates €53.00 Price Target for Lanxess (LXS)

Nord/LB set a €53.00 ($61.63) price target on Lanxess (ETR:LXS) in a research note issued to investors on Tuesday, Borsen Zeitung reports. The firm currently has a neutral rating on the stock.

LXS has been the subject of a number of other reports. Goldman Sachs Group set a €57.00 ($66.28) price target on shares of Lanxess and gave the stock a buy rating in a research report on Wednesday, January 23rd. DZ Bank reissued a neutral rating on shares of Lanxess in a research report on Thursday, January 24th. UBS Group set a €53.00 ($61.63) price target on shares of Lanxess and gave the stock a neutral rating in a research report on Friday, January 25th. Warburg Research set a €66.80 ($77.67) price target on shares of Lanxess and gave the stock a buy rating in a research report on Monday, February 11th. Finally, Commerzbank set a €64.00 ($74.42) price target on shares of Lanxess and gave the stock a buy rating in a research report on Tuesday, March 5th. Two equities research analysts have rated the stock with a sell rating, twelve have given a hold rating and nine have given a buy rating to the company’s stock. The stock presently has a consensus rating of Hold and an average target price of €61.72 ($71.76).

LXS stock opened at €49.66 ($57.74) on Tuesday. The company has a market capitalization of $4.37 billion and a P/E ratio of 10.82. The company has a quick ratio of 1.53, a current ratio of 2.61 and a debt-to-equity ratio of 101.71. Lanxess has a 52 week low of €39.47 ($45.90) and a 52 week high of €72.60 ($84.42).



About Lanxess

LANXESS Aktiengesellschaft, a specialty chemicals company, develops, manufactures, and markets chemical intermediates, specialty chemicals, and plastics worldwide. It operates in five segments: Advanced Intermediates, Specialty Additives, Performance Chemicals, Engineering Materials, and ARLANXEO. The Advanced Intermediates segment offers high-grade intermediates for the agrochemical and coating industries; fine chemicals as precursors and intermediates for the pharmaceutical, agrochemical, and specialty chemical industries; customer-specific specialties; organometallics; and tire chemicals.

Featured Story: What is an investor looking for in an SEC filing?

Analyst Recommendations for Lanxess (ETR:LXS)

Receive News & Ratings for Lanxess Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lanxess and related companies with MarketBeat.com's FREE daily email newsletter.